Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

When artificial intelligence meets PD-1/PD-L1 inhibitors: Population screening, response prediction and efficacy evaluation
Weiqiu Jin, Qingquan Luo
Computers in Biology and Medicine (2022) Vol. 145, pp. 105499-105499
Closed Access | Times Cited: 12

Showing 12 citing articles:

Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Yanyan Xu, Jingyuan Xiong, Xiyang Sun, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 12, pp. 4327-4347
Open Access | Times Cited: 125
The artificial intelligence and machine learning in lung cancer immunotherapy
Qing Gao, Luyu Yang, Mingjun Lu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 52
Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status
Dávid Dóra, Balázs Ligeti, Tamás Kovács, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy
Yurong Qin, Miaozhe Huo, Xingwu Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 14
Non-invasive decision support for clinical treatment of non-small cell lung cancer using a multiscale radiomics approach
Xingping Zhang, Guijuan Zhang, Xingting Qiu, et al.
Radiotherapy and Oncology (2024) Vol. 191, pp. 110082-110082
Closed Access | Times Cited: 5
A Comprehensive Review About the Use of Monoclonal Antibodies in Cancer Therapy
Angel A Justiz-Vaillant, Bijay Raj Pandit, Chandrashekhar Unakal, et al.
Antibodies (2025) Vol. 14, Iss. 2, pp. 35-35
Open Access
Correlation Between ImageJ and Conventional Manual Scoring Methods for Programmed Death-Ligand 1 Immuno-Histochemically Stained Sections
Rand Suleiman Al Taher, Manal A. Abbas, Khalid Halahleh, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 2
Contrast‐enhanced CT‐based radiomic analysis for determining the response to anti‐programmed death‐1 therapy in esophageal squamous cell carcinoma patients: A pilot study
Qinzhu Yang, Haofan Huang, Guizhi Zhang, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 33, pp. 3266-3274
Open Access | Times Cited: 5
The Applications of Artificial Intelligence in Digestive System Neoplasms: A Review
Shuaitong Zhang, Wei Mu, Di Dong, et al.
Health Data Science (2022) Vol. 3
Open Access | Times Cited: 8
CT-based multimodal deep learning for non-invasive overall survival prediction in advanced hepatocellular carcinoma patients treated with immunotherapy
Yujia Xia, Jie Zhou, Xiaolei Xun, et al.
Insights into Imaging (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Harnessing artificial intelligence for enhanced Parkinson’s disease management: Pathways, treatment, and prospects
Mohsina Patwekar, Faheem Patwekar, Syed Sanaullah, et al.
Trends in Immunotherapy (2023) Vol. 7, Iss. 2, pp. 2395-2395
Open Access | Times Cited: 2
Association of artificial intelligence-based immunoscore with the efficacy of chemoimmunotherapy in patients with advanced non-squamous non-small cell lung cancer: a multicentre retrospective study
Jiaqing Liu, Dongchen Sun, Shuoyu Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Page 1

Scroll to top